News

Fecal transplantation and molecular testing are among the new recommendations.

Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.

Infectious disease specialists and public health professionals in search of a to-do list for 2018 need look no further.

Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.

ViiV Healthcare has launched a phase 3 study to assess if adults with HIV-1 who have achieved viral suppression on a 3-drug regimen can maintain suppression when switched to a 2-drug regimen.

Efforts to curb antimicrobial resistance have hit a brick wall in India, where new research finds unapproved drug combinations are rampant.

A new systematic review of published research suggests that methotrexate could potentially be the best co-treatment option for chronic arthritis associated with the chikungunya virus.

The FDA has granted pre-market approval for a new HPV test that can detect and identify HPV genotypes that put women at increased risk for cervical cancer.

An international research team finds that targeting the social and risk networks of patients recently diagnosed with HIV is leading them to more patients unknowingly infected with the virus.

A Nebraska mother’s Facebook post has parents and health experts around the country wondering if an influenza B infection may have caused hives in a child who did not present with any other flu symptoms.

The Rhode Island Department of Health has issued a consumer alert regarding deli sliced meat and cheese sold at a local Stop & Shop due to potential Listeria contamination.

Following an outbreak of norovirus in Pyeongchang ahead of the Winter Olympics, health officials are taking steps to stem the outbreak and keep attendees healthy.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

In case you missed them, we've compiled a list of the latest US Food and Drug Administration (FDA) recalls posted this week.

The CDC’s acting director provides a somber flu update and stresses the need to stay vigilant against the virus.

A small portion of individuals with Lyme disease continue to have symptoms of arthritis long after treatment. Now, scientists think they have a better understanding of the cause of that lingering reaction.

Despite a new report indicating that the flu vaccine hasn’t been very effective in North America this year, health officials say it’s still a valuable weapon against this severe flu season.

CDC experts provide a flu update for clinicians via a COCA webinar.

The CDC’s ACIP voted to approve updated adult immunization schedule recommendations for adults aged 19 years or older.

The FDA approves Symfi Lo Tablets for the treatment of HIV-1 in adult and pediatric patients who weigh at least 35 kg.

Ideally, every individual with HIV would be able to receive ART in a timely fashion, but in resource-limited communities, it’s crucial to prioritize those who will most benefit.

The recent announcement that e-retailing giant Amazon, investment bank JP Morgan Chase, and multinational holding company Berkshire Hathaway are starting a health insurance company has incited mixed emotions among public health professionals.

Gilead Sciences, Inc.'s Biktarvy has been approved by the FDA for the treatment of those with HIV-1.

Grifols receives approval from the FDA for a new higher potency formulation of HyperRAB rabies immune globulin for rabies post-exposure prophylaxis.

Should SIGA's drug be approved, it will be the first treatment available for the deadly disease.

The FDA grants Mesa Biotech Inc.'s Accula Flu A/Flu B test 510(k) clearance and CLIA waiver.

Contagion® celebrates its second year this month amid celebrations of bringing in its highest readership traffic to-date.

Researchers from the Wellcome Sanger Institute and collaborators find that a multidrug-resistant strain of malaria spread throughout Cambodia 5 years before clinical resistance was even reported.